Expanded Access Program for RP in Adults
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Ocugen
Related studies linked through entity extraction aliases.
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
- Status
- RECRUITING
- Phase
- PHASE1
Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
- Status
- TERMINATED
- Phase
- PHASE3
Dry Eye Disease Study With Brimonidine
- Status
- COMPLETED
- Phase
- PHASE2
Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2